Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.68 | 17.35 |
| PEG Ratio (TTM) | 0.10 | 0.98 |
| P/S Ratio (TTM) | 0.30 | 1.36 |
| P/B Ratio (TTM) | 0.59 | 5.61 |
| P/FCF Ratio (TTM) | 100.89 | -9.93 |
| Price to 5YR AVG Earnings Ratio | 9.26 | 28.59 |
| Price to 5YR AVG FCF Ratio | 18.63 | 22.23 |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -5.02% | 5.63% |
| ROE (TTM) | -5.84% | 9.34% |
| Net Profit Margin (TTM) | -3.12% | 5.62% |
| ROIC 5YR AVG | 10.66% | 15.08% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -376.72% | 23.30% | -37.19% |
| Revenue | 11.67% | 21.78% | 9.31% |
| Net Income | -377.25% | 27.20% | -34.15% |
| Cash Flow | 7,786.72% | 182.14% | 97.99% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.63 | 2.10 |
| Quick Ratio (TTM) | 1.81 | 1.22 |
| D/E Ratio (TTM) | 0.05 | 3.30 |
| Interest Coverage (TTM) | -2.00 | 2.08 |
| Piotroski F-Score | 3 | 6 |
| Altman Z-Score | 4.41 | 3.58 |
| LTL to 5YR AVG FCF | 0.31 | 6.02 |
| Shares Outstanding Growth 5YR AVG | 1.94% | -0.28% |